Drug-drug Interaction Study Beteewn ASK120067 and Rifampicin or Itraconazole

Clinical trial NCT05631678 · COMPLETED

Trial details

NCT number: NCT05631678
Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic NSCLC

Start date: 2022-06-06
Primary completion: 2022-08-03
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.